UK researchers announced a breakthrough gene therapy that slowed Huntington’s disease for the first time. Early-stage trials at University College London showed some patients’ condition progressed 75% slower over three years. The therapy, AMT-130, is delivered via direct brain injection.
Related Posts
Tarcísio vai se Lula estiver mal
Tarcísio de Freitas (Republicanos) não desmente nem confirma candidatura à Presidência da República quando a conversa entre aliados envereda por…
Thousands demonstrate against Trump and Musk in ‘Hands Off!’ rallies across the US
Thousands of people gathered across the US on Saturday to rally for what’s expected to be the largest single day…
Newegg Is Taking $170 Off This 240Hz Gaming Monitor During Prime Day
We may earn a commission from links on this page. Deal pricing and availability subject to change after time of…